Detection of antibodies to hepatitis C virus in U.S. blood donors.

An enzyme immunoassay (EIA) which utilizes a solid phase coated with a recombinant antigen (c100-3) derived from the hepatitis C virus (HCV) genome was evaluated for efficacy in the detection of antibodies to HCV (anti-HCV). The sensitivity of the antibody test was demonstrated by the detection of a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dawson, G J, Lesniewski, R R, Stewart, J L, Boardway, K M, Gutierrez, R A, Pendy, L, Johnson, R G, Alcalde, X, Rote, K V, Devare, S G
Format: Artigo
Jezik:Inglês
Izdano: 1991
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC269816/
https://ncbi.nlm.nih.gov/pubmed/1709949
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items